Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05274009
Other study ID # H-11-21-7566
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2023
Est. completion date May 2024

Study information

Verified date October 2022
Source University of Ottawa
Contact Glen P Kenny, PhD
Phone 6135625800
Email gkenny@uottawa.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

With the increasing incidence and severity of extreme heat events accompanying climate change, there is an urgent need for sustainable cooling strategies to protect heat-vulnerable older adults, who are at increased risk of adverse health events during heat stress. Health agencies including the World Health Organization, the United States Centers for Disease Control and Prevention, and Health Canada currently recommend visiting a cooling centre or other air-conditioned location for 1-3 hours per day during extreme heat events to mitigate hyperthermia and strain on the cardiovascular system and therefore the risk adverse health events. However, our recent trial shows that while brief air-conditioning exposure is effective for reducing body temperature and cardiovascular burden in healthy older adults, the physiological impacts of cooling abate quickly following return to the heat. The purpose of this project is therefore to assess whether shorter but more frequent air-conditioning exposure provides more effective cooling than current recommendations (a single 1-3-hour cooling bout) in older adults with or without common chronic health conditions associated with increased vulnerability to extreme heat. This will be accomplished by evaluating physiological strain in older adults with and without diabetes and/or hypertension exposed for 8 hours to conditions reflective of extreme heat events in temperate, continental climates (35°C, 60% relative humidity). Participants will complete 3 separate simulated heat event exposures: i) a control trial (no cooling throughout the 8-hour heat event); ii) a recommended cooling trial (3 hours of heat exposure followed by 2 hours cooling); and iii) a hybrid cooling trial (2 hours of heat exposure followed by 1 hour cooling, another 2 hours heat exposure followed by 1 hour cooling, and a final 2-hour heat exposure).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date May 2024
Est. primary completion date May 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 85 Years
Eligibility Inclusion Criteria: - Adult aged 60-85 years - Male or female - Body mass index < 35 kg/m2 - For participants with type 2 diabetes: at least one year lapsed since diagnosis and hemoglobin A1c 6.0-10.5%. - For participants with hypertension: at least one year lapsed since diagnosis or average resting blood pressure >140 systolic or >90 diastolic Exclusion Criteria: - Currently smoking or quit <5 years ago - Moderate or serious medical conditions (other than Type 2 diabetes or high blood pressure), particularly those known to influence physiological responses to heat exposure (e.g., diagnosed heart disease, neurological disorders) - Heat adapted due to repeated exposure to hot environments (use sauna, recent travel to hot climates, other) - For participants with type 2 diabetes: "Brittle" diabetes: unpredictable hypo- & hyperglycemia. Severe cardiovascular autonomic or peripheral neuropathy (guidelines.diabetes.ca/cpg)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No cooling (control)
Participants are exposed to 35°C, 60% relative humidity for 8 hours.
Recommended cooling
Participants are exposed to 35°C, 60% relative humidity for 3 hours, are then moved to an air-conditioned room for 2 hours (~23°C, ~50% relative humidity), and then return to the heat for a final 3 hours.
Hybrid cooling
Participants are exposed to 35°C, 60% relative humidity for 2 hours, are moved to an air-conditioned room for 1 hour (~23°C, ~50% relative humidity), return to the heat for 2 hours, move back to the air-conditioned room for 1 hour, and then return to the heat for a final 2 hours

Locations

Country Name City State
Canada University of Ottawa Ottawa Ontario

Sponsors (1)

Lead Sponsor Collaborator
University of Ottawa

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Core temperature (peak) Peak rectal temperature measured during the 8-hour heat exposure. 8-hour heat exposure
Primary Core temperature (AUC) Rectal temperature will be measured continuously throughout each exposure and the area under the curve will be calculated. 8-hour heat exposure
Secondary Heart rate temperature (peak) Peak rectal temperature measured during the 8-hour heat exposure. 8-hour heat exposure
Secondary Heart rate (AUC) Heart rate will be measured continuously throughout each exposure and the area under the curve will be calculated. 8-hour heat exposure
Secondary Mean skin temperature Mean skin temperature calculated as a weighted average of skin temperatures at 8 body regions. Before and continuously throughout each 8 hour exposure
Secondary Arterial blood pressures Systolic and diastolic pressures measured in triplicate. Every hour during the 8-hour heat exposure
Secondary SDNN Standard deviation of normal-to-normal R-R intervals measured via 3-lead ECG. Every hour during the 8-hour heat exposure
Secondary RMSSD Root mean squared standard deviation of normal-to-normal R-R intervals measured via 3-lead ECG. Every hour during the 8-hour heat exposure
Secondary Rate pressure product Rate pressure product calculated as systolic blood pressure x heart rate. Every hour during the 8-hour heat exposure
Secondary Body fluid loss Body fluid loss calculated as a change in body weight from pre-exposure values (corrected for food intake and deification). Every hour during the 8-hour heat exposure
Secondary Stand test: 30:15 ratio 30:15 ratio calculated as the ratio of the RR interval measured after 30 heart beats following standing from a supine position to that measured after 15 heart beats. Prior to and following the 8-hour heat exposure
Secondary Stand test: Systolic response to standing Fall in systolic blood pressure after standing from a supine position. Prior to and following the 8-hour heat exposure
Secondary Baroreflex sensitivity Baroreflex sensitivity determined during cyclic stand-squat manoeuvres. Prior to and following the 8-hour heat exposure
Secondary Change in plasma volume Change in plasma volume calculated from venous blood samples (Dill and Costill technique) Prior to and following the 8-hour heat exposure
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A